These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 22367101)
21. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population. Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130 [TBL] [Abstract][Full Text] [Related]
22. Effect of cigarette smoking on paraoxonase 1 activity according to PON1 L55M and PON1 Q192R gene polymorphisms. Haj Mouhamed D; Ezzaher A; Mechri A; Neffati F; Omezzine A; Bouslama A; Gaha L; Douki W; Najjar MF Environ Health Prev Med; 2012 Jul; 17(4):316-21. PubMed ID: 22205545 [TBL] [Abstract][Full Text] [Related]
23. Association between Paraoxonase 1 (PON1) Polymorphisms and the Risk of Acute Coronary Syndrome in a North African Population. Bounafaa A; Berrougui H; Ghalim N; Nasser B; Bagri A; Moujahid A; Ikhlef S; Camponova P; Yamoul N; Simo OK; Essamadi A; Khalil A PLoS One; 2015; 10(8):e0133719. PubMed ID: 26241956 [TBL] [Abstract][Full Text] [Related]
24. Associations between paraoxonase 1 (PON1) polymorphisms and susceptibility and PON1 activity in rheumatoid arthritis patients, and comparison of PON1 activity in patients and controls: a meta-analysis. Bae SC; Lee YH Clin Rheumatol; 2019 Aug; 38(8):2141-2149. PubMed ID: 30868319 [TBL] [Abstract][Full Text] [Related]
25. Paraoxonase (PON1) polymorphisms Q192R and L55M are not associated with human longevity: A meta-analysis. Wei GZ; Zhu MY; Wang F; Zhao YG; Li SS; Liu TY; Luo Y; Tang WR Z Gerontol Geriatr; 2016 Jan; 49(1):24-31. PubMed ID: 25962362 [TBL] [Abstract][Full Text] [Related]
26. Paraoxonase 1 (PON1) Q192R genotypes and their interaction with smoking strongly increase atherogenicity and the Framingham risk score. Souza-Nogueira A; Camargo AE; Remondi FA; Paoliello MM; Richter RJ; Furlong CE; Barbosa DS; Maes M; Moreira EG Arch Endocrinol Metab; 2016 Oct; 60(5):426-435. PubMed ID: 27812605 [TBL] [Abstract][Full Text] [Related]
27. Polymorphisms in three obesity-related genes (LEP, LEPR, and PON1) and breast cancer risk: a meta-analysis. Liu C; Liu L Tumour Biol; 2011 Dec; 32(6):1233-40. PubMed ID: 21887553 [TBL] [Abstract][Full Text] [Related]
28. Association of paraoxonase 1 (PON1) L55M and PON1 Q192R gene polymorphisms and risk of psoriasis. Kalkan G; Seçkin HY; Benli İ; Akbaş A; Ateş Ö; Özyurt H; Baş Y; Oğrum A; Pancar GŞ G Ital Dermatol Venereol; 2019 Jun; 154(3):321-326. PubMed ID: 28399619 [TBL] [Abstract][Full Text] [Related]
29. Paraoxonase-1 55/192 genotypes in schizophrenic patients and their relatives in Turkish population. Kucukali CI; Aydin M; Ozkok E; Orhan N; Cakir U; Kilic G; Ozbek Z; Ince N; Kara I Psychiatr Genet; 2008 Dec; 18(6):289-94. PubMed ID: 19018234 [TBL] [Abstract][Full Text] [Related]
30. Do PON1-Q192R and PON1-L55M polymorphisms modify the effects of hypoxic training on paraoxonase and arylesterase activity? Yigittürk O; Turgay F; Kızıldağ S; Özsoylu D; Balcı GA J Sport Health Sci; 2023 Mar; 12(2):266-274. PubMed ID: 33188964 [TBL] [Abstract][Full Text] [Related]
31. PON1 polymorphisms are predictors of ability to attain HDL-C goals in statin-treated patients. de Souza JA; Menin A; Lima LO; Smiderle L; Hutz MH; Van Der Sand CR; Van Der Sand LC; Ferreira ME; Pires RC; Almeida S; Fiegenbaum M Clin Biochem; 2015 Nov; 48(16-17):1039-44. PubMed ID: 26079344 [TBL] [Abstract][Full Text] [Related]
32. Paraoxonase 1 polymorphisms (L55M and Q192R) as a genetic marker of diabetic nephropathy in youth with type 1 diabetes. Fekih O; Triki S; Rejeb J; Neffati F; Douki W; Ommezzine A; Chouchane S; Guediche MN; Bouslama A; Najjar MF Endokrynol Pol; 2017; 68(1):35-41. PubMed ID: 26884296 [TBL] [Abstract][Full Text] [Related]
34. Relationship of paraoxonase-1 Q192R genotypes and in-stent restenosis and re-stenting in Chinese patients after coronary stenting. Ma W; Liang Y; Zhu J; Chen T; Feng G; Yang Y; Liu X; Wang X Atherosclerosis; 2016 Aug; 251():305-310. PubMed ID: 27450784 [TBL] [Abstract][Full Text] [Related]
35. The genetic association between PON1 polymorphisms and osteonecrosis of femoral head: A case-control study. Li JM; Li Y; Wang L Medicine (Baltimore); 2017 Oct; 96(42):e8198. PubMed ID: 29049204 [TBL] [Abstract][Full Text] [Related]
36. Investigating paraoxonase-1 gene Q192R and L55M polymorphism in patients with renal cell cancer. Uyar OA; Kara M; Erol D; Ardicoglu A; Yuce H Genet Mol Res; 2011 Feb; 10(1):133-9. PubMed ID: 21308654 [TBL] [Abstract][Full Text] [Related]
37. Association between paraoxonase-1 gene polymorphisms and risk of metabolic syndrome. Kordi-Tamandani DM; Hashemi M; Sharifi N; Kaykhaei MA; Torkamanzehi A Mol Biol Rep; 2012 Feb; 39(2):937-43. PubMed ID: 21573798 [TBL] [Abstract][Full Text] [Related]
38. Paraoxonase 1 gene polymorphisms are associated with an increased risk of breast cancer in a population of Chinese women. Wu J; Fang M; Zhou X; Zhu B; Yang Z Oncotarget; 2017 Apr; 8(15):25362-25371. PubMed ID: 28445984 [TBL] [Abstract][Full Text] [Related]
39. PON1 L55M and Q192R gene polymorphisms and CAD risks in patients with hyperlipidemia : Clinical study of possible associations. Chen H; Ding S; Zhou M; Wu X; Liu X; Liu J; Wu Y; Liu D Herz; 2018 Nov; 43(7):642-648. PubMed ID: 28835968 [TBL] [Abstract][Full Text] [Related]
40. PON1 Q192R genotype influences clopidogrel responsiveness by relative platelet inhibition instead of on-treatment platelet reactivity. Li X; Zhang L; Chen X; Qu F; Li J; Ma C; Yang J; Xu B; Wang H; Xu Q; Zhang Y; Li Y; Lu C; Yin T Thromb Res; 2013 Oct; 132(4):444-9. PubMed ID: 23993903 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]